Prothena Corporation plc (PRTA)
NASDAQ: PRTA · Real-Time Price · USD
9.41
-0.04 (-0.48%)
Aug 24, 2026, 1:42 PM EDT - Market open
Prothena Corporation Market Cap
Prothena Corporation has a market cap or net worth of $482.82 million as of August 24, 2026. Its market cap has increased by 2.27% in one year.
Market Cap
482.82M
Enterprise Value
201.62M
1-Year Change
2.27%
Ranking
Category
Stock Price
$9.41
ChartMarket Cap Chart
Since December 21, 2012, Prothena Corporation's market cap has increased from $127.30M to $482.82M, an increase of 279.28%. That is a compound annual growth rate of 10.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 482.82M | -6.08% |
| Dec 31, 2025 | 514.10M | -31.02% |
| Dec 31, 2024 | 745.30M | -61.78% |
| Dec 29, 2023 | 1.95B | -33.09% |
| Dec 30, 2022 | 2.91B | 26.63% |
| Dec 31, 2021 | 2.30B | 380.02% |
| Dec 31, 2020 | 479.50M | -24.08% |
| Dec 31, 2019 | 631.60M | 53.82% |
| Dec 31, 2018 | 410.60M | -71.51% |
| Dec 29, 2017 | 1.44B | -15.04% |
| Dec 30, 2016 | 1.70B | -20.98% |
| Dec 31, 2015 | 2.15B | 277.66% |
| Dec 31, 2014 | 568.50M | -1.92% |
| Dec 31, 2013 | 579.60M | 347.22% |
| Dec 31, 2012 | 129.60M | 1.81% |
| Dec 21, 2012 | 127.30M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Evommune | 508.82M |
| BlossomHill Therapeutics | 501.94M |
| Ginkgo Bioworks Holdings | 498.32M |
| Relmada Therapeutics | 493.88M |
| C4 Therapeutics | 492.10M |
| ProKidney | 486.74M |
| Editas Medicine | 477.63M |
| Puma Biotechnology | 476.97M |